Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000906416-96-000070
Filing Date
1996-12-05
Accepted
1996-12-05 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 3 - 10/31/96 3 6045
  Complete submission text file 0000906416-96-000070.txt   7948
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-21589 | Film No.: 96676271
SIC: 2834 Pharmaceutical Preparations

Mailing Address 745 FIFTH AVENUE NEW YORK NY 10151-0050
Business Address 745 FIFTH AVENUE NEW YORK NY 10151-0050 2123632120
MCFADDEN GEORGE (Reporting) CIK: 0001026745 (see all company filings)